Back HIV Treatment Treatment Guidelines

HIV Treatment Guidelines

Updated U.S. Guidelines for Antiretroviral Treatment of Children with HIV

The U.S. Department of Health and Human Services has updated its Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. Reflecting recent data from the START and PENPACT1 trials, the guidelines now recommend that all children with HIV start antiretroviral therapy (ART) regardless of CD4 T-cell count, viral load, or clinical symptoms.

alt

Read more:

Updated Antiretroviral Therapy Guidelines Emphasize Benefits of Early HIV Treatment

The U.S. Department of Health and Human Services has updated itsGuidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents to reflect findings from the START and TEMPRANO trials demonstrating the clinical benefits of early initiation of antiretroviral therapy (ART) with a pre-treatment CD4 T-cell count above 500 cells/mm3.

alt

Read more:

Genvoya Pill with Tenofovir Alafenamide Added to Recommended HIV Regimens

The Department of Health and Human (DHHS) Panel on Antiretroviral Guidelines for Adults and Adolescents has added the recently approved Genvoya single-tablet regimen containing elvitegravir and the new tenofovir alafenamide to its list of recommended regimens for initial HIV treatment.

alt

Read more:

WHO Issues Recommendations on Linkage to Care, Retention to Help Bring HIV Treatment to All

The World Health Organization (WHO) has issued new recommendations on how to organize services in order to promote linkage to care and retention in care as part of its new guidelines recommending antiretroviral treatment for all adults and adolescents diagnosed with HIV.

alt

Read more:

Coverage of the 15th European AIDS Conference

HIVandHepatitis.com coverage of the 15th European AIDS Conference, sponsored by the European AIDS Clinical Society (EACS), October 21-14, 2015, in Barcelona.

Conference highlights include antiretroviral therapy and treatment strategies, new European HIV treatment guidelines, HIV pre-exposure prophylaxis (PrEP), and treatment for hepatitis C.

Full listing by topic

15th European AIDS Conference website

10/28/15

alt